Wen Rong, Shi Yifeng, Gao Yuan, Xu Yangyang, Xiong Botao, Li Denghui, Gong Feilong, Wang Wei
Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, People's Republic of China.
Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, People's Republic of China.
World Neurosurg. 2019 Mar;123:371-377. doi: 10.1016/j.wneu.2018.12.046. Epub 2018 Dec 22.
This meta-analysis is to evaluate the clinical efficacy of gamma knife radiosurgery (GKRS) for treating cavernous malformations.
PubMed, Ovid Embase, and Ovid Medline electronic databases were searched. The primary outcome is hemorrhage rate and this meta-analysis is performed.
Nine studies are included in this meta-analysis. The overall risk ratio (RR) of hemorrhage rate of pre-GKRS and post-GKRS is 6.08 (95% confidence interval [CI], 5.04-7.35). The overall RR is 3.03 (95% CI, 2.65-4.11) between the hemorrhage rate of pre-GKRS and the first 2 years postradiosurgery, and the overall RR is 12.13 (95% CI, 1.73-85.07) comparing pre-GKRS with 2 years after GKRS. There is no significant difference of the hemorrhage rate between the first 2 years postradiosurgery and 2 years after GKRS (RR = 2.81; 95% CI, 0.20-13.42). The neurologic deficiency is the most common radiosurgery-related complication.
Patients with cerebral cavernous malformations, especially ones that were deep seated and surgically inaccessible, seem to benefit from GKRS owing to a reduction of annual hemorrhage rate in the first 2 years and 2 years after, despite several cases that suffer from negative side effects of radiation.
本荟萃分析旨在评估伽玛刀放射外科治疗(GKRS)海绵状血管畸形的临床疗效。
检索了PubMed、Ovid Embase和Ovid Medline电子数据库。主要结局指标为出血率,并进行了本荟萃分析。
本荟萃分析纳入了9项研究。GKRS治疗前与治疗后的出血率总体风险比(RR)为6.08(95%置信区间[CI],5.04 - 7.35)。GKRS治疗前与放射外科治疗后前2年的出血率总体RR为3.03(95%CI,2.65 - 4.11),将GKRS治疗前与GKRS治疗后2年进行比较,总体RR为12.13(95%CI,1.73 - 85.07)。放射外科治疗后前2年与GKRS治疗后2年的出血率无显著差异(RR = 2.81;95%CI,0.20 - 13.42)。神经功能缺损是最常见的与放射外科治疗相关的并发症。
患有脑海绵状血管畸形的患者,尤其是那些位置较深且手术难以触及的患者,似乎受益于GKRS,因为在治疗后的前2年和2年每年出血率有所降低,尽管有几例患者出现了放疗的负面副作用。